Lithium Carbonate vs Nivolumab

## Lithium Carbonate vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Lithium Carbonate** and **Nivolumab**.

## Mechanism of Action

**Lithium Carbonate**: Modulates intracellular signaling via inositol and GSK-3 inhibition.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Lithium Carbonate — 18-36 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Lithium Carbonate — Li2CO3; Nivolumab — N/A.

**Molecular Weight**: Lithium Carbonate — 73.8910 g/mol; Nivolumab — N/A.

**Type**: Lithium Carbonate — Small molecule; Nivolumab — Antibody.